Real-world effectiveness with the recommended single dose of respiratory syncytial virus (RSV) vaccination dipped in older ...

Researchers at University of Tsukuba have demonstrated that during Japan's COVID-19 booster vaccination campaign, online information influenced vaccination intentions in ways similar to the initial ...

Some countries are planning to wait up to 12 weeks to administer second doses of COVID-19 vaccines. Will this slow the virus?

The effectiveness of a single respiratory syncytial virus (RSV) vaccine dose declined among older adults, potentially suggesting the need for booster shots among this demographic. That is according to ...

Thanks to KiwiCo for supporting this episode of SciShow! Vaccines teach your immune system to recognize pathogens, but sometimes your body needs a bit of a reminder. Hosted by: Hank Green SciShow has ...

Valneva's Phase 2 data show strong, lasting immunity for its Pfizer-partnered Lyme vaccine as the company consolidates operations in France.

Heading into the holidays, what are the symptoms to watch for, who is most at risk for whooping cough and who needs to get ...

Most US teens have received a dose of the meningococcal vaccine, yet uptake of the first dose and completion of the booster ...

Scientists create a vaccine that shields against Crimean-Congo hemorrhagic fever within days and protects for over a year.

Investing.com -- Valneva SE stock rises after the company reported final positive Phase II data for its Lyme disease vaccine candidate VLA15, showing strong immune responses following a third annual ...

COVID-19 risk might be much lower than in past summers, but it’s not gone - making a pre-Christmas booster for some a good idea.

Massachusetts grants $9.1 million for youth substance misuse prevention, with programs in high and middle schools focusing on early intervention, as per a state news release.